Unknown

Dataset Information

0

Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability.

ABSTRACT: Overgrowth disorders are a heterogeneous group of conditions characterized by increased growth parameters and other variable clinical features such as intellectual disability and facial dysmorphism. To identify new causes of human overgrowth, we performed exome sequencing in ten proband-parent trios and detected two de novo DNMT3A mutations. We identified 11 additional de novo mutations by sequencing DNMT3A in a further 142 individuals with overgrowth. The mutations alter residues in functional DNMT3A domains, and protein modeling suggests that they interfere with domain-domain interactions and histone binding. Similar mutations were not present in 1,000 UK population controls (13/152 cases versus 0/1,000 controls; P < 0.0001). Mutation carriers had a distinctive facial appearance, intellectual disability and greater height. DNMT3A encodes a DNA methyltransferase essential for establishing methylation during embryogenesis and is commonly somatically mutated in acute myeloid leukemia. Thus, DNMT3A joins an emerging group of epigenetic DNA- and histone-modifying genes associated with both developmental growth disorders and hematological malignancies.

SUBMITTER: Tatton-Brown K 

PROVIDER: S-EPMC3981653 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Overgrowth disorders are a heterogeneous group of conditions characterized by increased growth parameters and other variable clinical features such as intellectual disability and facial dysmorphism. To identify new causes of human overgrowth, we performed exome sequencing in ten proband-parent trios and detected two de novo DNMT3A mutations. We identified 11 additional de novo mutations by sequencing DNMT3A in a further 142 individuals with overgrowth. The mutations alter residues in functional  ...[more]

Similar Datasets

Unknown Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability.
| S-EPMC5420355 | biostudies-literature
Transcriptomics NONO mutations cause syndromic intellectual disability and inhibitory synaptic defects
2015-09-02 | E-MTAB-2895 | biostudies-arrayexpress
Transcriptomics NONO mutations cause syndromic intellectual disability and inhibitory synaptic defects
2015-09-02 | E-MTAB-2894 | biostudies-arrayexpress
Unknown De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability.
| S-EPMC3980521 | biostudies-literature
Unknown NR2F1 mutations cause optic atrophy with intellectual disability.
| S-EPMC3928641 | biostudies-literature
Unknown Mutations in NSUN2 cause autosomal-recessive intellectual disability.
| S-EPMC3376487 | biostudies-literature
Transcriptomics De novo mutations in the genome organizer CTCF cause Intellectual Disability
2013-06-01 | E-GEOD-46833 | biostudies-arrayexpress
Transcriptomics De novo mutations in the genome organizer CTCF cause Intellectual Disability
2013-06-01 | GSE46833 | GEO
Unknown Mutations in SNX14 cause a distinctive autosomal-recessive cerebellar ataxia and intellectual disability syndrome.
| S-EPMC4225633 | biostudies-literature
Unknown Mutations in ANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malformations, and macrodontia.
| S-EPMC3155157 | biostudies-literature